NEW YORK, Sept. 3, 2025 /PRNewswire/ -- Today, EMED Technologies, a global leader in drug delivery and infusion therapy innovation, today announced the issuance of U.S. Patent No. 12,403,243 that ...

Seemant Shukla, CEO of Quantum Asset Management Co., said global headwinds, including US inflation, tariffs, and pressure on ...

ForCast’s lead program, FC001, has received both Orphan Drug Designation and Qualified Infectious Disease Program (QIDP) designation from the US Food & Drug Administration, which enable eligibility ...

Vedantu is in discussions with investors to potentially raise an additional $20–$25 million in primary and secondary capital ...

TSC Life announces FDA clearance of its moderate to high flow blood and fluid warmer, Fluido® AirGuard System, in the U.S.

Addcomposites Oy, a Finnish composite manufacturing automation company, launched a comprehensive suite of free, browser-based ...

Advanced Blood Flow Imaging Enhances Precision of Artificial Heart DesignUsing magnetic cameras, researchers at Linköping ...

The dramatic growth of a key federal drug discount program has fueled debate about whether it is helping low-income patients ...

Viridian Therapeutics (VRDN) offers a differentiated next-gen therapy for Thyroid Eye Disease, targeting a large, underpenetrated market dominated ...

The Odessa American is the leading source of local news, information, entertainment and sports for the Permian Basin.